A melanoma vaccine just cut recurrence or death risk by 42%
Original headline: World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial
What happened
A trial of a cancer vaccine for melanoma reported a 42% reduction in the risk of recurrence or death. Researchers described the result as unprecedented in cancer drug development.
- Funny
- 1/10
- Wild
- 4/10
- Legit
- 8/10
Worth your time?
0